Virginia M. Klimek, MD

Pictured: Virginia Klimek

Internist and medical oncologist Virginia Klimek discusses the importance of research, clinical trials, and patient education in finding new treatments for myelodysplastic syndromes (MDS).


I am a board-certified medical oncologist with a clinical and research focus on bone marrow failure syndromes, including myelodysplastic syndromes (MDS) and aplastic anemia. Because these conditions can sometimes turn into acute leukemia, I also have experience in the treatment of acute myelogenous leukemia (AML). My research interests also include the study of “therapy-related” MDS and leukemia, which can develop after treatment with radiation or chemotherapy for another cancer.

I feel fortunate to be at Memorial Sloan Kettering Cancer Center where we have a team approach to managing bone marrow failure syndromes. I work with pathologists who are dedicated to the study and review of bone marrow samples, and a stem cell transplant program that offers a full range of stem cell transplant options, including stem cell transplants for people with marrow diseases up to the age of 70.

Appointments for New Patients
Clinical Expertise

Myelodysplastic Syndromes; Aplastic Anemia; Acute Myelogenous Leukemia

Languages Spoken

MD, University of Medicine and Dentistry of New Jersey


North Shore University Hospital


Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine, Medical Oncology

Publications by Virginia M. Klimek
Visit PubMed for full listing of Virginia M. Klimek journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.